ATEC Growth Surges on Strength of PTP Procedure
The company grew more than 60% in the first quarter of 2022 as it continues expanding its portfolio and geographic footprint. May 11, 2022
ZimVie Makes Needed Cuts in First Quarter of 2022
The company declined in the mid-teens in 1Q22 as it exited unprofitable geographies and optimized its portfolio for longer term growth. May 10, 2022
CONMED Grows on Strength of March Recovery
The company grew less than 1% in the first quarter of 2022 as macro environment pressures disrupted both January and February. May 10, 2022
NuVasive Grows Presence in Cervical and International Markets
The company grew in the high single digits for 1Q22 as elective procedures returned to key markets in the second half of the quarter. May 09, 2022
Orthofix Sales Accelerated Late in First Quarter
The company grew around 1% in 1Q22 on the strength of new product introductions and international stocking orders. May 09, 2022
Zimmer Biomet Beats Expectations for Early 2022
The company grew in the low single digits for 1Q22 as a strong recovery in elective procedures offset other headwinds. May 04, 2022
Smith+Nephew Welcomes Encouraging Start to 2022
The company grew in the low single digits for the first quarter and expects the orthopedic market's recovery to accelerate throughout 2022 May 03, 2022
Stryker’s Early 2022 Growth Constrained by Supply Pressures
The company grew in the mid-single digits for 1Q22 as procedure recovery fueled growth. However, supply chain pressures offset some gains. Apr 29, 2022
DePuy Synthes’ ASC Focus Spurs Knee and Hip Growth
The company grew in the low single digits for 1Q22, driven in part by knee replacement and hip replacement gains in the ASC setting. Apr 20, 2022
Orthopedic Market Unlikely to Find Reprieve in 2022
Based on their commentary in the fourth quarter of 2021, orthopedic executives expect market disruption to persist through 2022. Mar 23, 2022
